Reagents News: Breaking Reagents News, Comments and Articles.

BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress

BOTHELL, Wash., May 23, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTC:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced its participation at the Terrapinn World Stem Cells & Regenerative Medicine Congress 2013 this week...

Scientists develop powerful new method for finding therapeutic antibodies

(Scripps Research Institute) Scientists at the Scripps Research Institute have devised a powerful new technique for finding antibodies that have a desired biological effect. Antibodies, which can bind to billions of distinct targets, are already used...

BD Issues 2012 Sustainability Report

FRANKLIN LAKES, N.J., May 22, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the publication of its 2012 Sustainability Report. This is BD's fifth Sustainability Report and it continues to focus on the Company's shared value approach to sustainability. "We believe the principles of shared value — creati...

Proteostasis Therapeutics Presents Preclinical Data on Parkinson’s Disease and Cystic Fibrosis Targets at EMBO Conference

Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, today presented data on the Company’s preclinical targets for Parkinson’s disease and cystic fibrosis at a conference hosted by the European Molecular Biology Organizatio...

BD Board Declares Dividend

FRANKLIN LAKES, N.J., May 21, 2013 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX) has declared a quarterly dividend of 49.5 cents per common share, payable on June 28, 2013 to holders of record on June 7, 2013. The indicated annual dividend rate is $1.98 per share. About BDBD is a leading global medical technology company that develops, ma...

From Novel Research to Innovative Medicines: GlaxoSmithKline Launches Discovery Fast Track Competition for Academic Researchers

Scientists in U.S., Canada Challenged to Submit Groundbreaking Research Proposals for Chance at Collaborative Partnership Focused on Drug Discovery GlaxoSmithKline plc (GSK) today announced the launch of Discovery Fast Track, a competition designed to accelerate the translation of academic research into novel therapies. Winners of the competition will...

The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research

ALBANY, New York, May 21, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Biochip Products and Services Market (Microarrays, Reagents, Drug Discovery, Life Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market was valu...

BioTime CEO Dr. Michael West to Present at USC Minisymposium: Musculoskeletal Development and Repair

BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the USC Minisymposium: Musculoskeletal Development and Repair conference at the Keck School of Medicine, the University of Southern California, on...

DVS Sciences CyTOF® Mass Cytometer Featured in Paper Selected to Receive the Cytometry A 2012 Best Paper Award

DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research technology, today announced that its CyTOF® Mass Cytometer was used in an award winning paper. The paper, Single-Cell Mass Cytometry Adapted to Measurements of the Cell Cycle, published in Cytometry Part A (81A:552-56...

Proteomics Market - Mass Spectrometry & Biochips 2017 Forecast & Analysis in New Research Report at ReportsnReports.com

“Proteomics: Technologies and Global Markets” is the new market research report added to ReportsnReports.com store. Dallas, Texas (PRWEB) May 20, 2013 The main objective for the present report is to present the up-to-date market picture for proteomics into a single comprehensive report. The objective was to capture the changing industry dynamics and market shift occurring in this industry....

New Release of Accelrys Electronic Lab Notebook Transforms Laboratory Operations

SAN DIEGO, May 20, 2013 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the latest release of the Accelrys Electronic Lab Notebook (AELN), which now offers extensive integration with the unifying, scientifically aware Accelrys Enterprise Platform (AEP). Expanded integration with AEP supports the management...

Sony Delivers New Technology for Science to CYTO 2013

CHAMPAIGN, Ill., May 17, 2013 /PRNewswire/ -- Sony Biotechnology Inc. ("Sony") today announced the launch of the new SH800 Cell Sorter 8-well strip holder and 130um sorting chip.  Sony will also be exhibiting its newly rebranded reagent portfolio. New data collected on its new SH800 Cell Sorter, the EC800 flow cytometer, and new SP6800 Spectral Analyzer will be presented during commercia...

Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color

CHAMPAIGN, Ill., May 17, 2013 /PRNewswire/ -- Sony Biotechnology Inc. ("Sony") today announced the launch of the new Sony SP6800 Spectral Analyzer (SP6800).  Sony will be exhibiting and taking orders for this system at CYTO 2013, which will be held at the San Diego Convention Center in San Diego, California, from May 20 - 22.  The SP6800 Spectral Analyzer is Sony's second analytic...

Source BioScience Interim Management Statement

16th May 2013: Source BioScience plc (LSE: SBS), the international diagnostic and genetic analysis services business, today publishes its Interim Management Statement for the year to date. Unless otherwise stated, the financial information referenced below refers to the four months ended 30 April 2013, and the corresponding period last year, this being the latest practicable date to which f...

ERBA Diagnostics’ Compliance Plan Accepted By NYSE MKT

ERBA Diagnostics Delays Filing Its Quarterly Report on Form 10-Q and Provides Preliminary Financial Information ERBA Diagnostics, Inc. (NYSE MKT: ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that the Company received a letter from NYSE MKT LLC (the “Exchange”) stating that the Exchange has accepted the...

Illumina Announces Partnerships to Automate TruSeq® and Nextera® Sample Preparation Kits

Automation Methods Developed By Leading Vendors Will Enable Customers to Accelerate Testing and Discovery Illumina, Inc. (NASDAQ:ILMN) today announced it is collaborating with leading providers of liquid handling robotic platforms to develop automation methods for its best-in-class TruSeq and Nextera Sample Preparation kits. Initial partners in this ef...

Pre-Clinical Imaging Market Research Report Submitted by Transparency Market Research

Albany, NY, May 15, 2013 --(PR.com)-- Pre-clinical imaging is an efficient tool for the evaluation of the anatomical, functional, and physiological status of any organ at a cellular and molecular level. This technology plays an important role in the analysis of the properties and effects of any drug or therapy. It helps in understanding the pathophysiology and other characters of any disease. The...

J. Craig Venter Institute's Mobile Genomics Lab Launches First School Visits in San Diego County

LA JOLLA, Calif., May 14, 2013 /PRNewswire-USNewswire/ -- The J. Craig Venter Institute (JCVI) announced today the launch of their mobile genomics laboratory program in the San Diego, California area.  The DiscoverGenomics! Mobile Laboratory is a self-sufficient laboratory on wheels providing middle school students and teachers an opportunity to learn current bioscience concepts and to m...

ChanTest Develops New Cardiotoxicity and Contractility Assay with Human Stem Cell Cardiomyocytes

ChanTest has developed a new assay using ACEA Bioscience’s xCELLigence System, creating several algorithms for twitch detection and kinetic analysis, and has concluded an investigation that suggests twitch impedance is a sensitive tool to assess contraction in a relatively high-throughput assay. Cleveland, OH (PRWEB) May 14, 2013 Cardiovascular (CV) toxicity is a leading contributor to drug wit...

Thermic Fluid Market is Expected to Reach USD 2.78 Billion Globally by 2018: Transparency Market Research

ALBANY, New York, May 13, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Thermic Fluid Market by Product (Silicone and Aromatics, Mineral Oils, GlycolBased Fluids, etc.), by Application (Oil and Gas, Chemicals, Solar, Pharmaceuticals, etc.) - Global Industry Analysis, S...

Global Cell Culture Market - New Market Research Report Published by Transparency Market Research

Albany, New York (PRWEB) May 13, 2013 The growth of this market is driven by the shift towards use of live model systems for drug discovery and evaluation, use of animal-derived component-free media and reagents, and growing demand for advanced bi...

NEB Releases a New Site-Directed Mutagenesis Kit for Both Standard and Novel Uses, Including Long Insertions and Deletions

IPSWICH, Mass., May 10, 2013 /PRNewswire/ -- New England Biolabs (NEB), a world leader in the discovery and production of reagents for the life science industry, launched a new reagent kit for site-directed mutagenesis (SDM). The Q5® Site-Directed Mutagenesis Kit (Q5 SDM Kit) is capable of introducing long insertions and deletions, thus allowing a broader range of applications for this widely...

ScinoPharm Taiwan and Coland Holdings Establish Strategic Alliance for Oncological Injectable Products for China

TAINAN, Taiwan, May 10, 2013 /PRNewswire/ -- ScinoPharm Taiwan Ltd. (TSE: 1789.TW) and Coland Holdings Ltd. (TSE: 4144.TW) announced today that they have formed a strategic alliance to develop a series of generic oncological drugs for Mainland China. Several Active Pharmaceutical Ingredients (APIs) have been initially selected for development and future sales as injectable formulation product...

SomaLogic technology used to discover protein

SomaLogic® technology used to discover protein that reverses age-­related cardiac hypertrophy in mice  Unbiased proteomic approach helps researchers identify blood-­based factor that holds promise for treating human cardiac failure In a s...

Cambio provides Microzone PCR and DNA reagents to life science market

Cambio, distributor of high-quality life science products in the UK, is able to supply its customers with a selection of reagents by Microzone. MegaMix, microLYSIS® and MicroCLEAN are each specifically designed as convenient and efficient solutions for PCR, DNA release and DNA clean-up respectively. By incorporating these reagents into their procedures, life scientists can save time that would...